HALB (Halberd) Long-Term Debt: $0.15 Mil (As of Jul. 2023)


What is Halberd Long-Term Debt?

Halberd HALB Long-Term Debt is $0.15 Mil as of Jul. 2023.

Halberd's Long-Term Debt for the quarter that ended in Jul. 2023 was $0.15 Mil.

Halberd's quarterly Long-Term Debt increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.15 Mil) but then stayed the same from Jul. 2022 ($0.15 Mil) to Jul. 2023 ($0.15 Mil).

Halberd's annual Long-Term Debt increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.15 Mil) but then stayed the same from Jul. 2022 ($0.15 Mil) to Jul. 2023 ($0.15 Mil).

Halberd  (OTCPK:HALB) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Halberd Long-Term Debt Related Terms

Halberd Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Halberd's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd Long-Term Debt Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Long-Term Debt
0.00 0.15 0.15

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Long-Term Debt 0.00 0.15 0.15
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.15 Mil mean?
Halberd (HALB) has a Long-Term Debt of $0.15 Mil as of Jul. 2023.
Is Halberd's Long-Term Debt too high?
Halberd's current Long-Term Debt is $0.15 Mil.
How does Halberd's Long-Term Debt compare to GRI and OCEA?
Halberd's Long-Term Debt of $0.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Halberd's current Long-Term Debt is $0.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Halberd stock overvalued right now?
Halberd (HALB) has a current Long-Term Debt of $0.15 Mil. The current Long-Term Debt is $0.15 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Halberd (HALB), the current Long-Term Debt is $0.15 Mil as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.